RQ-01

N/A

Report date: 2023/10/10 20:05:08
NME

Base Information

Drug NameRQ-01
Drug Alias NameRQ-01RQ-001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionViral fusion proteins inhibitors
TargetsViral fusion proteins
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Metapneumovirus infectionsCoronavirus Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRed Queen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRed Queen Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Metapneumovirus infectionsCoronavirus Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A